PRN / 8 hours ago
VANCOUVER, BC: ImmunoFlex, a life sciences company developing clinically validated, pharmaceutical grade natural health products based on advancements in genomics research, today announced the approval of FLEX 10 by Health Canada.
At ImmunoFlex, we work with the immune system to strengthen, support, and enhance our body's natural surveillance and response system. said ImmunoFlex CEO Chris Wagner.
FLEX 10 is the first product in our line up of products designed to achieve this goal so we could not be more delighted with the Health Canada approval.
FLEX 10 is the first product in our line up of products designed to achieve this goal so we could not be more delighted with the Health Canada approval.
